Hence, it is possible that TSG-6 physically inhibits the catalytic activity of MMP14 and protects CD44 cleavage to CD44ICD from MMP14 to reduce HSC activation and liver fibrosis in mice with ALD. This evidence concerns the gene TNFAIP6 and Hepatic fibrosis.